Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder.[L6010,L52145]
Synonyms
Desamfetamina
(+)-amphetamine
(S)-(+)-β-phenylisopropylamine
(S)-(+)-amphetamine
Dextroamphetamine saccharate
Dexamphetamine
Dexanfetamina
(S)-α-methylbenzeneethanamine
(αS)-α-methylbenzeneethanamine
Dexamfetamine
Dextroamphetamine
(S)-1-phenyl-2-propylamine
Dextroamphetamine adipate
(S)-amphetamine
Dexamfetaminum
Dextroamphetamine sulfate
(+)-(S)-amphetamine
(+)-α-methylphenethylamine
(S)-1-phenyl-2-aminopropane
(+)-α-methylphenylethylamine
d-amphetamine
Dexamfetamina
Brand Names
Apo-dextroamphetamine SR
Dexedrine
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER
Dextrostat
Procentra
Mixed Salts of a Single Entity Amphetamine Product XR
Adderall XR
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
